Connect with us

Technology

United Breast Cancer Foundation is Collaborating with LifeVac for Breast Cancer Awareness Month

Published

on

LifeVac donates $10 to UBCF for every Pink LifeVac anti-choking kit sold in October

HUNTINGTON STATION, N.Y., Oct. 23, 2024 /PRNewswire-PRWeb/ — United Breast Cancer Foundation (UBCF) is proud to announce their collaboration with LifeVac this October to celebrate and support Breast Cancer Awareness Month. LifeVac is a choking rescue device produced in the USA and designed to save lives. Portable and non-invasive, LifeVac helps people respond quickly and effectively to choking emergencies.

LifeVac is a choking rescue device produced in the USA and designed to save lives. Through October 31, 2024, for every Pink LifeVac kit purchased, $10 will be donated directly to UBCF to help provide support to breast cancer patients, survivors, and their families.

Through October 31, 2024, for every Pink LifeVac Travel kit or Pink bundle purchased, $10 will be donated directly to UBCF to help provide support to breast cancer patients, survivors, and their families. The Pink LifeVac kit would make a great baby shower gift or simply to have on-hand for your family, especially during the holidays.

LifeVac is a patented, FDA registered Class II medical device, and the Pink LifeVac kit can be found online at http://www.LifeVac.net. Make sure to select the Pink Bundle or the Pink Travel Kit to receive this amazing life-saving device and support United Breast Cancer Foundation. There’s no prescription needed, and LifeVac is covered by HSA/FSA accounts.

“UBCF and LifeVac are two organizations interested in helping people and saving lives. Through our work together, we are educating the community and raising awareness for our important causes,” said Stephanie Mastroianni, Executive Director of UBCF. “By purchasing a Pink LifeVac device, you’re not only protecting your family, you’re helping others directly impacted by breast cancer. Thank you for your purchase this October!”

According to ACS, one in eight women will be diagnosed with breast cancer in their lifetime, and when detected early and localized, breast cancer has a 99% 5-year survival rate. This October, and all year round, UBCF encourages women and men to know their bodies and learn the self-breast exam to help recognize any changes.

For more information about this and other events sponsored by UBCF, please visit (website or link). To make a donation and help support UBCF’s mission, please visit ubcf.org.

Go online and make your Pink LifeVac kit purchase today. One kit covers an entire family for life. In the event the device is used to save a life, LifeVac will replace it for free.

About UBCF:
United Breast Cancer Foundation is a non-profit founded in 2000 with a mission to make a positive difference in the lives of those impacted by breast cancer. UBCF is committed to gifting helpful and supportive donated items and funding breast health and wellness services focused on education, screening, treatment, recovery, and wellness. The platinum rated, 4-star charity offers numerous life-supporting patient and family programs available to women, men, and families nationwide. Tax-deductible contributions (consult your tax advisor) may be made towards UBCF’s programs. UBCF accepts contributions through Donor Advised Funds and vehicle and real estate donations as well. Combined Federal Campaign #77934.

Media Contact

Beth Reichart, United Breast Cancer Foundation, 877-822-4287, Beth@ubcf.org, UBCF.org

Twitter

View original content to download multimedia:https://www.prweb.com/releases/united-breast-cancer-foundation-is-collaborating-with-lifevac-for-breast-cancer-awareness-month-302283922.html

SOURCE United Breast Cancer Foundation

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Talos Unveils New Portfolio Management System for Digital Assets

Published

on

By

Integration with OEMS Delivers Full Investment Lifecycle Platform

NEW YORK, Oct. 23, 2024 /PRNewswire/ — Talos, the premier provider of institutional trading technology for digital assets, today announced the launch of its new Portfolio Management System (PMS), seamlessly integrating all of its portfolio management tools with its flagship order and execution management system (OEMS). This new offering delivers comprehensive front-to-back support for portfolio managers, traders, risk managers, and operations teams, expanding Talos’s platform to a complete investment management system for digital assets.

With the introduction of this PMS, the Talos platform now offers institutions real-time risk monitoring for spot and derivatives, leveraging the risk technology recently added through Talos’s acquisition of Cloudwall. These capabilities are combined with Talos’s existing treasury and settlement capabilities, which include the ability to track positions, monitor P&L, and settle credit with OTC dealers. Together, these features allow institutions to manage their entire digital asset portfolio with a unified view of positions, P&L, and risk across multiple strategies.

“Digital assets are entering a new era of maturity, and our clients’ needs are expanding beyond execution into all aspects of investment management,” said Anton Katz, CEO and Co-Founder of Talos. “With the launch of our integrated PMS, Talos is not only meeting the evolving demands of our existing trading clients but is also opening the door to a broader range of institutions, such as venture capital firms and blockchain foundations, looking to manage their portfolios and treasuries. This expansion advances our mission to fully integrate digital assets into capital markets by providing institutions with the most comprehensive suite of tools.”

The Talos PMS offers key features such as live risk monitoring, portfolio roll-ups for aggregated views at multiple levels, continuous reconciliation with approximately 60 exchanges and OTC venues, and flexible pricing inputs to calculate P&L. Its integration with Talos’s OEMS introduces the construct of “Workspaces” for different user profiles across the investment lifecycle – portfolio managers, researchers, traders, risk managers and operations teams – creating a truly seamless experience for institutional investors on a single platform.

Earlier this year, Talos integrated into its core platform the portfolio construction technology acquired from D3X Systems which supports the design and management of systematic investment strategies, including tools for strategy backtesting, portfolio optimization and rebalancing.

About Talos

Talos provides institutional-grade technology that supports the full digital asset investment lifecycle, including liquidity sourcing, price discovery, trading, settlement, lending, borrowing, and portfolio management. Engineered by a team with unmatched experience building institutional trading and portfolio systems, the Talos platform connects institutions to key participants in today’s digital asset ecosystem – exchanges, OTC desks, prime brokers, lenders, custodians, and more – through a single interface. For additional information, visit www.talos.com.

Disclaimer: Talos Global, Inc. and its affiliates (“Talos”) offer software-as-a-service products that provide connectivity tools for institutional clients. Talos does not provide clients with any pre-negotiated arrangements with liquidity providers or other parties. Clients are required to independently negotiate arrangements with liquidity providers and other parties bilaterally. Talos is not party to any of these arrangements. Services and venues may not be available in all jurisdictions. For information about which services are available in your jurisdiction, please reach out to your sales representative. Talos is not is not an investment advisor or broker/dealer. This document and information do not constitute an offer to buy or sell, or a promotion or recommendation of, any digital asset, security, derivative, commodity, financial instrument or product or trading strategy. This document and information are not intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. This document and information are subject to change without notice. It is provided only for general informational, illustrative, and/or marketing purposes, or in connection with exploratory conversations with institutional investors and is not intended for retail clients. The information provided was obtained from sources believed to be reliable at the time of preparation, however Talos makes no representation as to its accuracy, suitability, non-infringement of third-party rights, or otherwise. Talos disclaims all liability, expenses, or costs arising from or connected with the information provided.

Media Contact:  media@talos.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/talos-unveils-new-portfolio-management-system-for-digital-assets-302283701.html

SOURCE Talos Trading

Continue Reading

Technology

Canadian Multifamily Market: Moderating Growth and Persistent Supply Challenges

Published

on

By

Rent growth slows, vacancies stay low, supply struggles to catch up, Yardi reports

TORONTO, Oct. 23, 2024 /PRNewswire/ — Yardi® Canada has released its latest multifamily report for Q3 2024, providing insights into Canada’s evolving apartment market. The report, based on anonymized data from 476,000 units across 5,400 properties, highlights slowing rent growth, persistently low vacancy rates and continued pressures from high housing demand.

Despite a modest economic recovery and a slight decrease in inflation, Canada’s apartment market remains tight. Policymakers face ongoing challenges in addressing the housing shortage, with new supply slow to meet growing demand.

Key findings from Q3 2024 Report:

Trending markets emerge: New RentCafe.com data reveals Winnipeg as the top trending places for renters, followed by Saskatoon and EdmontonRent growth slows: National in-place rent rose 6.2 precent year-over-year to $1,547, with growth deceleratingVacancy remains tight: Vacancy rate lifted to 3.2 percent, the highest since 2022, but turnover remains low

Peter Altobelli, vice president and general manager of Yardi Canada, noted: “The Canadian apartment market remains resilient, but the growing gap between housing demand and supply is shaping rental conditions. Although rent growth has cooled slightly, affordability remains a major issue for renters across the country.”

For a deeper analysis of the Q3 data, download the full report here.

About Yardi:

Celebrating 40 years of innovation, Yardi® develops industry-leading software for real estate companies worldwide. With over 9,500 employees, Yardi is dedicated to driving innovation and helping clients succeed in the real estate industry. For more information, visit yardi.com.

Logo: https://mma.prnewswire.com/media/737275/Yardi_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/canadian-multifamily-market-moderating-growth-and-persistent-supply-challenges-302283567.html

Continue Reading

Technology

Olympus Enters Partnership with Global Health Tech Company Proximie

Published

on

By

CENTER VALLEY, Pa., Oct. 23, 2024 /PRNewswire/ — Olympus Corporation is now offering its healthcare customers a market-leading health tech platform for digitizing operating rooms through a new global partnership with Proximie, a health technology company. Proximie’s cloud-based solution allows physicians to share real-time live clinical video, audio and imagery from the OR with colleagues and vendor partners globally. The system is designed to help hospitals promote and drive clinical and operational best practices by growing teaching opportunities and reaching more learners.

The partnership with Proximie will further Olympus’ aim to improve patient outcomes and clinical practices by tackling boundaries and connecting physicians, surgeons, clinicians and students. Telecollaboration is an important component in Olympus’ overall portfolio of medical solutions and is considered essential by many healthcare providers and teaching institutions. 

The terms of the partnership vary by region. In the U.S. and Canada, the agreement is a preferred partnership. 

Proximie’s device-agnostic platform allows for real-time collaboration, to schedule secure training sessions, as well as the ability to capture video from any source. Other key features include:

Software to enable access from any browser or mobile device.Seeing essential views of a procedure with up to four high definition, low-latency video feeds.Facilitating collaboration with annotation, chat, and screen sharing.Tablet control and ability to connect multiple video signals for quick installation on any tower or clinical space.Moderating capability with comprehensive controls and privacy features.Content management capabilities allowing users to transform individual expertise into shareable video content.

Proximie offerings can operate on a standalone tower or integrate seamlessly with other solutions.

“We’re thrilled to join forces with Proximie to provide our customers with a top-tier digital health platform including telecollaboration capabilities,” said Engin Demirel, Global Head of Commercialization Endoscopy Solutions Ecosystem (ESE) and EMEA Head of ESE at Olympus Corporation. “This partnership will help break down learning barriers and provide healthcare professionals with access to the knowledge needed to enhance patient care and outcomes. Such collaborations are crucial for the future of digital healthcare.”

“We are delighted to formalize our global partnership with the Olympus Corporation. It demonstrates our commitment to widening access to surgical and procedural knowledge, improving global healthcare equity,” said Dr. Nadine Hachach-Haram, Proximie founder and CEO. “As an agnostic solution for the healthcare sector, we are committed to widening our global impact, supporting surgeons to meet rising demand for diagnostic and interventional care and help improve patient outcomes.”

About Olympus

At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide best-in-class solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states.

For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world.

Olympus Corporation of the Americas, a wholly owned subsidiary of Olympus Corporation, is headquartered in Center Valley, Pennsylvania, USA, and employs more than 4,500 employees throughout locations in North and South America. For more information, visit www.olympusamerica.com.

About Proximie

Proximie is a global health technology platform focused on digitising operating and diagnostic rooms. Proximie’s mission is to make surgery more accessible, efficient, and effective for everyone, via cutting-edge, cloud-based technology.

The Proximie platform serves as a connectivity hub for the modern operating room, facilitating telepresence, content, and data management. This provides real-time insights for clinical teams, administrators, educators, trainees, tech companies, and medical device vendors, offering a single, reliable source of truth.

By opening-up surgery beyond traditional operating room boundaries, Proximie is facilitating a rich, insightful data set which naturally feeds best practices into the entire healthcare ecosystem. For more information, please visit www.proximie.com or follow @Proximie on Twitter and LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/olympus-enters-partnership-with-global-health-tech-company-proximie-302283852.html

SOURCE Olympus Corporation

Continue Reading

Trending